Mga Batayang Estadistika
| CIK | 1521065 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Drug Free Solution, Inc.
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| April 25, 2019 |
DSOL / Drug Free Solution Inc. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Drug Free Solution, Inc. (Exact name of registrant as specified in its charter) Nevada 333-175525 9 |
|
| April 25, 2019 |
Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event Reported): February 17, 2015 DRUG FREE SOLUTION, INC. (Exact Name of Registrant as Specified in Charter) Nevada 333-175525 99-0365611 (State or Other Jurisdiction of Incorporation) (Commission |
|
| March 14, 2019 |
8-K 1 form8-k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 14, 2019 DRUG FREE SOLUTION, INC. (formerly known as Living Breathing Project, Inc.) (Exact name of registrant as specified in its charter) Nevada 333-175525 99- |
|
| January 30, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 29, 2019 DRUG FREE SOLUTION, INC. |
|
| April 7, 2015 |
Unregistered Sales of Equity Securities, Results of Operations and Financial Condition, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 30, 2015 Drug Free Solution Inc. (Exact name of registrant as specified in its charter) Nevada 333-175525 99-0365611 (State or Other Jurisdiction (Commission (I.R.S. Employer |
|
| March 19, 2015 |
Letter from PKF O’Connor Davies * EX-16.1 2 ex16-1.htm March 18, 2015 Securities and Exchange Commission 100 F Street N.E. Washington, DC 20549 Re: Drug Free Solutions, Inc. Commission File Number – 333-175525 Ladies and Gentlemen: We have read Item 4.01 of Form 8-K of Drug Free Solutions, Inc. to be filed with the Securities and Exchange Commission and are in agreement with the statements contained under Item 4.01 therein as they |
|
| March 19, 2015 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant, Other Events FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 17, 2015 DRUG FREE SOLUTIONS, INC. (Exact name of registrant as specified in its charter) Commission File Number: 333-175525 Nevada 99-036511 (State or other jurisdi |
|
| January 30, 2015 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 2, 2014 DRUG FREE SOLUTIONS, INC. (Exact name of registrant as specified in its charter) Commission File Number: 333-175525 Nevada 99-036511 (State or other jurisdict |
|
| October 2, 2014 |
Drug Free Solution FORM 10-Q (Quarterly Report) 10-Q 1 v38957110q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended February 28, 2014 Commission File Number: 333-175525 drug free solution Inc. (formerly known as Living Breath Project, Inc.) (Exact name of registrant as specified i |
|
| September 2, 2014 |
DSOL / Drug Free Solution Inc. NT 10-K - - FORM NT 10-K NT 10-K 1 form12b-25.htm FORM NT 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): SEC FILE NUMBER 333-175525 [ x ] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period Ended: May 31, 2014 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Tra |
|
| April 15, 2014 |
DRUG FREE SOLUTION, INC.: Form 12b-25 - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): SEC FILE NUMBER 333-175525 [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [ x ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period Ended: February 28, 2014 [ ] Transition Report on Form 10-K [ ] Trans |
|
| January 14, 2014 |
Drug Free Solution, Inc.: Form 12b-25 - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [ x ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period Ended: November 30, 2013 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ |
|
| October 17, 2013 |
EX-3.1 2 exhibit3-1.htm EXHIBIT 3.1 |
|
| October 17, 2013 |
Living Breath Project, Inc.: Form 8K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 15, 2013 LIVING BREATH PROJECT, INC. (Exact name of registrant as specified in its charter) Nevada 333-175525 |
|
| August 29, 2013 |
NT 10-K 1 form12b25.htm FORM NT 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): [ x ] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period Ended: May 31, 2013 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K |
|
| April 18, 2013 |
Living Breath Project, Inc.: Form 8-K - Filed by newsfilecorp.com SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 12, 2013 LIVING BREATH PROJECT, INC. (formerly known as Dilmax Corp.) (Exact name of registrant as specified in its charter) Ne |
|
| April 12, 2013 |
Living Breath Project, Inc.: Form 12b-25 - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [ x ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period Ended: February 28, 2013 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20- |
|
| January 14, 2013 |
Living Breath Project, Inc.: Form 12b-25 - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [ x ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period Ended: November 30, 2012 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20- |
|
| November 8, 2012 |
Amended and Restated Articles of Incorporation ADDENDUM TO THE ARTICLES OF INCORPORATION OF DILMAX CORP. PURSUANT TO SECTION 78.035 OF THE NEVADA REVISED STATUTES ARTICLE II The address of the Corporation's registered office in the State of Nevada is 2360 Corporate Circle, Suite 400, Henderson, Nevada 89074-7722. ARTICLE III The purpose of the Corporation shall be to engage in any lawful act or activity for which corporations may be organized |
|
| November 8, 2012 |
Dilmax Corp - Form 8-K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 6, 2012 DILMAX CORP. (Exact name of registrant as specified in its charter) Nevada 333-175525 99-0365611 (State or Other Ju |
|
| October 11, 2012 |
Entry into a Material Definitive Agreement - CURRENT REPORT Dilmax Corp.: Form 8-K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 10, 2012 DILMAX CORP. (Exact name of registrant as specified in its charter) Nevada 333-175525 99-0365611 (State or Other Ju |
|
| October 3, 2012 |
Dilmax Corp.: Form 8-K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 1, 2012 DILMAX CORP. (Exact name of registrant as specified in its charter) Nevada 333-175525 99-0365611 (State or Other Jur |
